UNCY stock

Unicycive Therapeutics Inc (UNCY) financials · $195.0M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Unicycive Therapeutics Inc (UNCY) $195.0M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$29.5M-$32.1M
Net Income-$26.6M-$36.7M
EPS (Diluted)-$1.67-$0.56
Cached annual balance sheet
LineFY2025FY2024
Total Assets$49.1M$31.7M
Current Assets$49.0M$30.9M
Cash & Equivalents$29.2M$26.1M
PP&E$66.0K$75.0K
Total Liabilities$18.9M$24.2M
Current Liabilities$18.9M$24.1M
Shareholders' Equity$30.2M$7.43M
Retained Earnings-$127.8M-$101.3M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$31.3M-$28.6M
CapEx$24.0K$72.0K
Investing Cash Flow-$12.1M-$72.0K
Financing Cash Flow$46.5M$45.1M
Dividends PaidN/A$1.09M
Free Cash Flow-$31.3M-$28.6M
These statements as JSON? API free 100/day

FAQ

What is UNCY P/E and revenue?

Unicycive Therapeutics Inc (UNCY) $195.0M cap.

What is UNCY revenue?

UNCY income-statement cache has no revenue figure yet.

Is UNCY profitable?

Unicycive Therapeutics Inc last cached net income is -$26.6M (FY2025).

What are UNCY total assets?

Unicycive Therapeutics Inc last cached total assets are $49.1M (FY2025).

What is UNCY free cash flow?

Unicycive Therapeutics Inc last cached free cash flow is -$31.3M (FY2025).

Not investment advice. Cached statements, not a live tape.